Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Debt / NOTE 3.000%12/0
-
Market price (% of par)
-
106.0%
-
Total 13F principal
-
$73,369,512
-
Principal change
-
-$15,460,970
-
Total reported market value
-
$77,711,438
-
Number of holders
-
21
-
Value change
-
-$16,451,182
-
Number of buys
-
9
-
Number of sells
-
7
Institutional Holders of ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 as of Q1 2017
As of 31 Mar 2017,
ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 was held by
21 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$73,369,512
in principal (par value) of the bond.
The largest 10 bondholders included
DLD Asset Management, LP, FMR LLC, Allianz Asset Management GmbH, WOLVERINE ASSET MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, PERCEPTIVE ADVISORS LLC, Worth Venture Partners, LLC, GABELLI FUNDS LLC, Jefferies Group LLC, and CAMDEN ASSET MANAGEMENT L P /CA.
This page lists
21
institutional bondholders reporting positions
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.